✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of insulin aspart in patients with Type 2 diabetes: Assessment using a meal tolerance test under clinical conditions

✍ Scribed by Hitoshi Ando; Seiichiro Kurita; Akiko Shimizu; Ken-ichiro Kato; Kazuhide Ishikura; Koumei Taji; Masafumi Uno; Yumie Takeshita; Hirofumi Misu; Akio Fujimura; Shuichi Kaneko; Toshinari Takamura

Book ID: 115170629
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 434 KB
Volume: 39
Category: Article
ISSN: 0305-1870
DOI: 10.1111/j.1440-1681.2012.05708.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative pharmacodynamic and pharmaco

Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes

✍ G. B. Bolli; S. Luzio; S. Marzotti; F. Porcellati; C. Sert-Langeron; B. Charbonn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

Population Pharmacodynamic Modeling of H

Population Pharmacodynamic Modeling of Hyperglycemic Clamp and Meal Tolerance Tests in Patients with Type 2 Diabetes Mellitus

✍ Ying Hong, Jasper Dingemanse, Patricia Sidharta, Donald E. Mager 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 884 KB

Pharmacokinetics, Pharmacodynamics, and

Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study

✍ Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

Pharmacodynamics, Pharmacokinetics, Safe

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

✍ Matthews, Jessica E.; Stewart, Murray W.; De Boever, Erika H.; Dobbins, Robert L 📂 Article 📅 2008 🏛 Endocrine Society 🌐 English ⚖ 156 KB

Comparison of insulin lispro mixture 25/

Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes

✍ P. Roach; J. K. Malone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Ragaglitazar: The Pharmacokinetics, Phar

Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes

✍ Skrumsager, B. K.; Nielsen, K. K.; Müller, M.; Pabst, G.; Drake, P. G.; Edsberg, 📂 Article 📅 2003 🏛 Sage Publications 🌐 English ⚖ 193 KB